Monomeric G-protein, Rhes, is not an imidazoline-regulated protein in pancreatic β-cells

Vladimir V. Sharoyko, Irina I. Zaitseva, Mark Varsanyi, Neil Portwood, Barbara Leibiger, Ingo Leibiger, Per Olof Berggren, Suad Efendić, Sergei V. Zaitsev

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The monomeric G-protein, Rhes, is a candidate imidazoline-regulated molecule involved in mediating the insulin secretory response to efaroxan [S.L. Chan, L.K. Monks, H. Gao, P. Deaville, N.G. Morgan, Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell, Br. J. Pharmacol. 136 (1) (2002) 31-36]. This suggestion was based on observations regarding changes in Rhes mRNA expression in rat islets and pancreatic β-cells after prolonged culture with efaroxan, leading to desensitization of the insulin response to the compound. To verify this report, we have evaluated the effects of the imidazoline compounds efaroxan and BL11282 on Rhes mRNA expression in isolated rat pancreatic islets maintained in conditions identical to those used by Chan et al. The results demonstrate that desensitization of the insulin response to efaroxan, or to another imidazoline, BL11282, does not change Rhes mRNA expression levels. Transfection of MIN6 cells with plasmids containing Rhes or Rhes-antisense also does not alter efaroxan- or BL11282-induced insulin secretion. Together, these data do not support the hypothesis that Rhes is an imidazoline-regulated protein.

Original languageEnglish
Pages (from-to)1455-1459
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume338
Issue number3
DOIs
StatePublished - Dec 23 2005
Externally publishedYes

Fingerprint

efaroxan
Imidazolines
BL 11282
Monomeric GTP-Binding Proteins
Insulin
Proteins
Islets of Langerhans
Messenger RNA
Rats
Insulin-Secreting Cells
Transfection
Plasmids

Keywords

  • BL11282
  • Desensitization
  • Efaroxan
  • Imidazolines
  • Insulin secretion
  • MIN6 cells
  • Pancreatic islets

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Sharoyko, V. V., Zaitseva, I. I., Varsanyi, M., Portwood, N., Leibiger, B., Leibiger, I., ... Zaitsev, S. V. (2005). Monomeric G-protein, Rhes, is not an imidazoline-regulated protein in pancreatic β-cells. Biochemical and Biophysical Research Communications, 338(3), 1455-1459. https://doi.org/10.1016/j.bbrc.2005.10.145

Monomeric G-protein, Rhes, is not an imidazoline-regulated protein in pancreatic β-cells. / Sharoyko, Vladimir V.; Zaitseva, Irina I.; Varsanyi, Mark; Portwood, Neil; Leibiger, Barbara; Leibiger, Ingo; Berggren, Per Olof; Efendić, Suad; Zaitsev, Sergei V.

In: Biochemical and Biophysical Research Communications, Vol. 338, No. 3, 23.12.2005, p. 1455-1459.

Research output: Contribution to journalArticle

Sharoyko, VV, Zaitseva, II, Varsanyi, M, Portwood, N, Leibiger, B, Leibiger, I, Berggren, PO, Efendić, S & Zaitsev, SV 2005, 'Monomeric G-protein, Rhes, is not an imidazoline-regulated protein in pancreatic β-cells', Biochemical and Biophysical Research Communications, vol. 338, no. 3, pp. 1455-1459. https://doi.org/10.1016/j.bbrc.2005.10.145
Sharoyko, Vladimir V. ; Zaitseva, Irina I. ; Varsanyi, Mark ; Portwood, Neil ; Leibiger, Barbara ; Leibiger, Ingo ; Berggren, Per Olof ; Efendić, Suad ; Zaitsev, Sergei V. / Monomeric G-protein, Rhes, is not an imidazoline-regulated protein in pancreatic β-cells. In: Biochemical and Biophysical Research Communications. 2005 ; Vol. 338, No. 3. pp. 1455-1459.
@article{f0de901c15b94352824a52c76adad8ef,
title = "Monomeric G-protein, Rhes, is not an imidazoline-regulated protein in pancreatic β-cells",
abstract = "The monomeric G-protein, Rhes, is a candidate imidazoline-regulated molecule involved in mediating the insulin secretory response to efaroxan [S.L. Chan, L.K. Monks, H. Gao, P. Deaville, N.G. Morgan, Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell, Br. J. Pharmacol. 136 (1) (2002) 31-36]. This suggestion was based on observations regarding changes in Rhes mRNA expression in rat islets and pancreatic β-cells after prolonged culture with efaroxan, leading to desensitization of the insulin response to the compound. To verify this report, we have evaluated the effects of the imidazoline compounds efaroxan and BL11282 on Rhes mRNA expression in isolated rat pancreatic islets maintained in conditions identical to those used by Chan et al. The results demonstrate that desensitization of the insulin response to efaroxan, or to another imidazoline, BL11282, does not change Rhes mRNA expression levels. Transfection of MIN6 cells with plasmids containing Rhes or Rhes-antisense also does not alter efaroxan- or BL11282-induced insulin secretion. Together, these data do not support the hypothesis that Rhes is an imidazoline-regulated protein.",
keywords = "BL11282, Desensitization, Efaroxan, Imidazolines, Insulin secretion, MIN6 cells, Pancreatic islets",
author = "Sharoyko, {Vladimir V.} and Zaitseva, {Irina I.} and Mark Varsanyi and Neil Portwood and Barbara Leibiger and Ingo Leibiger and Berggren, {Per Olof} and Suad Efendić and Zaitsev, {Sergei V.}",
year = "2005",
month = "12",
day = "23",
doi = "10.1016/j.bbrc.2005.10.145",
language = "English",
volume = "338",
pages = "1455--1459",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Monomeric G-protein, Rhes, is not an imidazoline-regulated protein in pancreatic β-cells

AU - Sharoyko, Vladimir V.

AU - Zaitseva, Irina I.

AU - Varsanyi, Mark

AU - Portwood, Neil

AU - Leibiger, Barbara

AU - Leibiger, Ingo

AU - Berggren, Per Olof

AU - Efendić, Suad

AU - Zaitsev, Sergei V.

PY - 2005/12/23

Y1 - 2005/12/23

N2 - The monomeric G-protein, Rhes, is a candidate imidazoline-regulated molecule involved in mediating the insulin secretory response to efaroxan [S.L. Chan, L.K. Monks, H. Gao, P. Deaville, N.G. Morgan, Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell, Br. J. Pharmacol. 136 (1) (2002) 31-36]. This suggestion was based on observations regarding changes in Rhes mRNA expression in rat islets and pancreatic β-cells after prolonged culture with efaroxan, leading to desensitization of the insulin response to the compound. To verify this report, we have evaluated the effects of the imidazoline compounds efaroxan and BL11282 on Rhes mRNA expression in isolated rat pancreatic islets maintained in conditions identical to those used by Chan et al. The results demonstrate that desensitization of the insulin response to efaroxan, or to another imidazoline, BL11282, does not change Rhes mRNA expression levels. Transfection of MIN6 cells with plasmids containing Rhes or Rhes-antisense also does not alter efaroxan- or BL11282-induced insulin secretion. Together, these data do not support the hypothesis that Rhes is an imidazoline-regulated protein.

AB - The monomeric G-protein, Rhes, is a candidate imidazoline-regulated molecule involved in mediating the insulin secretory response to efaroxan [S.L. Chan, L.K. Monks, H. Gao, P. Deaville, N.G. Morgan, Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell, Br. J. Pharmacol. 136 (1) (2002) 31-36]. This suggestion was based on observations regarding changes in Rhes mRNA expression in rat islets and pancreatic β-cells after prolonged culture with efaroxan, leading to desensitization of the insulin response to the compound. To verify this report, we have evaluated the effects of the imidazoline compounds efaroxan and BL11282 on Rhes mRNA expression in isolated rat pancreatic islets maintained in conditions identical to those used by Chan et al. The results demonstrate that desensitization of the insulin response to efaroxan, or to another imidazoline, BL11282, does not change Rhes mRNA expression levels. Transfection of MIN6 cells with plasmids containing Rhes or Rhes-antisense also does not alter efaroxan- or BL11282-induced insulin secretion. Together, these data do not support the hypothesis that Rhes is an imidazoline-regulated protein.

KW - BL11282

KW - Desensitization

KW - Efaroxan

KW - Imidazolines

KW - Insulin secretion

KW - MIN6 cells

KW - Pancreatic islets

UR - http://www.scopus.com/inward/record.url?scp=27744471356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744471356&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.10.145

DO - 10.1016/j.bbrc.2005.10.145

M3 - Article

VL - 338

SP - 1455

EP - 1459

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -